Medtronic Quarterly Balance Sheet
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medtronic financial position
As of Jul 31, 2026, Medtronic reported total assets of $93.31 billion, up 2.6% from a year earlier against total liabilities of $42.46 billion. Shareholders' equity stood at $50.23 billion, or 53.8% of assets. The company held $1.69 billion in cash and equivalents against $28.15 billion of debt, a net debt position of $26.46 billion.
The current ratio (current assets divided by current liabilities) was 2.07, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.56.
Summary generated from market data by MetaCap's automated system. Methodology
Medtronic balance sheet (quarterly)
| Quarter (USD) | Q1 20272026-07-31 | Q4 20262026-04-24 | Q3 20262026-01-23 | Q2 20262025-10-24 | Q1 20262025-07-25 | Q4 20252025-04-25 | Q3 20252025-01-24 | Q2 20252024-10-25 | Q1 20252024-07-26 | Q4 20242024-04-26 | Q3 20242024-01-26 | Q2 20242023-10-27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.69B | 1.95B | 1.15B | 1.28B | 1.27B | 2.22B | 1.24B | 1.39B | 1.31B | 1.28B | 1.62B | 1.31B |
| Short-Term Investments | 7.13B | 7.27B | 7.24B | 7.04B | 6.85B | 6.75B | 6.68B | 6.59B | 6.53B | 6.72B | 6.70B | 6.42B |
| Receivables | 6.36B | 6.64B | 6.36B | 6.39B | 6.26B | 6.51B | 6.12B | 6.26B | 6.01B | 6.13B | 5.97B | 5.93B |
| Inventory | 6.21B | 5.95B | 6.31B | 6.16B | 5.89B | 5.48B | 5.61B | 5.48B | 5.41B | 5.22B | 5.73B | 5.75B |
| Total Current Assets | 24.39B | 24.79B | 24.07B | 24.00B | 23.22B | 23.81B | 22.51B | 22.44B | 21.95B | 21.93B | 22.51B | 22.08B |
| Property, Plant & Equipment | 7.47B | 7.42B | 7.18B | 7.16B | 7.01B | 6.84B | 6.59B | 6.44B | 6.28B | 6.13B | 5.84B | 5.74B |
| Goodwill | 43.19B | 42.59B | 41.89B | 41.81B | 42.01B | 41.74B | 40.82B | 41.16B | 41.08B | 40.99B | 41.16B | 40.82B |
| Intangible Assets | 10.24B | 10.15B | 10.34B | 10.77B | 11.22B | 11.67B | 12.18B | 12.42B | 12.82B | 13.22B | 13.69B | 14.06B |
| Total Assets | 93.31B | 93.03B | 91.48B | 91.35B | 90.97B | 91.68B | 89.97B | 90.04B | 89.75B | 89.98B | 90.84B | 90.09B |
| Accounts Payable | 2.69B | 2.64B | 2.57B | 2.58B | 2.56B | 2.45B | 2.29B | 2.38B | 2.29B | 2.41B | 1.99B | 2.17B |
| Short-Term Debt | 2.54B | 1.79B | 191.00M | 1.42B | 2.43B | 2.87B | 2.62B | 3.72B | 1.55B | 1.09B | 1.03B | 1.34B |
| Total Current Liabilities | 11.80B | 11.66B | 9.49B | 9.94B | 11.53B | 12.88B | 11.84B | 12.20B | 10.29B | 10.79B | 9.79B | 9.66B |
| Long-Term Debt | 25.62B | 26.17B | 27.88B | 27.68B | 26.18B | 25.64B | 23.98B | 24.61B | 26.31B | 23.93B | 24.15B | 23.74B |
| Total Liabilities | 42.46B | 42.96B | 42.29B | 42.49B | 42.84B | 43.42B | 40.36B | 41.33B | 41.59B | 39.56B | 38.84B | 38.44B |
| Shareholders' Equity | 50.23B | 49.46B | 48.98B | 48.65B | 47.89B | 48.02B | 49.39B | 48.49B | 47.95B | 50.21B | 51.79B | 51.46B |
| Retained Earnings | 33.19B | 32.64B | 32.30B | 32.07B | 31.61B | 31.48B | 31.32B | 30.92B | 30.55B | 30.40B | 30.66B | 30.26B |
| Total Debt | 28.15B | 27.96B | 28.07B | 29.10B | 28.61B | 28.52B | 26.61B | 28.33B | 27.86B | 25.02B | 25.18B | 25.08B |
| Net Cash (Debt) | -19.33B | -18.74B | -19.69B | -20.77B | -20.49B | -19.55B | -18.68B | -20.34B | -20.02B | -17.02B | -16.86B | -17.35B |
| Shares Outstanding | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.31B | 1.33B | 1.33B |
This table shows 12 quarterly periods of Medtronic's balance sheet, from Q1 2027 back to Q2 2024, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MDT's reporting calendar. What is a balance sheet?